Clinical Trials
27 trialsRapid dFLC Response Predict CHR in AL Amyloidosis
Peking University People's Hospital
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
Wake Forest University Health Sciences
Umbilical Cord Blood Transplantation From Unrelated Donors
University of Rochester
BRALLA
Instituto do Cancer do Estado de São Paulo
STFREiYTNBC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Sun Yat-sen University
METRO
Vastra Gotaland Region
LALPh2022
PETHEMA Foundation
PORTRAIT
Vall d'Hebron Institute of Oncology
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
Ruijin Hospital
Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients
Moscow Clinical Scientific Center
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Da, Yuwei, M.D.
Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344
Alliance for Clinical Trials in Oncology
Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy
First Affiliated Hospital of Harbin Medical University
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer
Peking University
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
University of California, San Francisco
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Duke University
MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
Hoffmann-La Roche
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
Fujian Medical University
A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
Hoosier Cancer Research Network
LABC
Barretos Cancer Hospital
Q-lite
Czech CLL Study Group
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
National Cancer Institute (NCI)
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
National Cancer Institute (NCI)
Chemotherapeutic Agents in Brain/Breast
Case Comprehensive Cancer Center